Filing Details

Accession Number:
0001415889-22-011492
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-17 16:09:50
Reporting Period:
2022-11-17
Accepted Time:
2022-11-17 16:09:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185945 A Chris Rallis C/O Fennec Pharmaceuticals, Inc.
Po Box 13628, 68 Tw Alexander Drive
Research Triangle Park NC 27709
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2022-11-17 333 $7.99 30,018 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold pursuant to a 10b5-1 plan on November 17, 2022.